{"id":6469,"date":"2025-01-09T15:16:54","date_gmt":"2025-01-09T15:16:54","guid":{"rendered":"https:\/\/vichsec.org\/?post_type=guideline&#038;p=6469"},"modified":"2025-01-09T15:19:14","modified_gmt":"2025-01-09T15:19:14","slug":"efficacy-of-anthelmintics-specific-recommendations-for-canines-revision-1","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/fr\/guidline\/efficacy-of-anthelmintics-specific-recommendations-for-canines-revision-1\/","title":{"rendered":"Efficacy of anthelmintics: specific recommendations for canines (Revision 1)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Revised VICH GL19 (R1) (Anthelmintics &#8211; Canines) &#8211; October 2024 &#8211; For implementation at step 7 in the regions by October 2025<\/p>\n","protected":false},"menu_order":17,"template":"","meta":[],"guideline_category":[132],"class_list":["post-6469","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-efficacy-anthelmintics"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline\/6469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/media?parent=6469"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline_category?post=6469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}